Effects of febuxostat combined with hemodialysis on chronic kidney disease and effect on fibroblast growth factor 23 and bone metabolism

ZHANG Jing, YANG Xiaoning, LI Lina, PAN Xiaomi

PDF(1520 KB)
主办：上海医药工业研究院
　　　中国药学会
ISSN 1672-9188   CN 31-1939/R   SLYHAA
World Clinical Drug
PDF(1520 KB)
World Clinical Drug ›› 2023, Vol. 44 ›› Issue (06) : 632-637. DOI: 10.13683/j.wph.2023.06.020
Article

Effects of febuxostat combined with hemodialysis on chronic kidney disease and effect on fibroblast growth factor 23 and bone metabolism

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2023, 44(06): 632-637 https://doi.org/10.13683/j.wph.2023.06.020

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(1520 KB)

Accesses

Citation

Detail
Sections
Recommended

/

〈 〉